65 investors urge drugmakers to tie bonuses to vaccine equity

A group of 65 investment firms are urging drug companies to include global COVID-19 vaccine equity targets as part of their executive compensation policies.

Advertisement

The firms, which control nearly $3.5 trillion in assets worldwide, include asset managers, pension funds and insurers.

“What we’re asking the companies to do is to tie their remuneration policy and strategy to a more equitable distribution of the vaccine,” Rogier Krens, chief investment officer of Achmea Investment Management, told BBC News.

If drug companies fail to improve vaccine distribution, executive bonuses could be withheld, Mr. Krens said.

View the full article here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.